Advertisement
Screener

Inari Medical, Inc. Stock-Based Compensation

Inari Medical, Inc. Stock-Based Compensation

Inari Medical, Inc. reported Stock-Based Compensation of $38.86 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-10-28.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2024-10-28

  • Inari Medical, Inc. share-based payment arrangement, noncash expense for the quarter ending 2024-09-30 was $12.95M, a 31.56% increase year-over-year.
  • Inari Medical, Inc. share-based payment arrangement, noncash expense for the quarter ending 2024-06-30 was $13.04M, a 25.94% increase year-over-year.
  • Inari Medical, Inc. share-based payment arrangement, noncash expense for the quarter ending 2024-03-31 was $12.87M, a 24.48% increase year-over-year.
  • Inari Medical, Inc. share-based payment arrangement, noncash expense for the quarter ending 2023-12-31 was $9.80M, a 29.03% increase year-over-year.
  • Inari Medical, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $40.34M, a 40.69% increase from fiscal 2022.
  • Inari Medical, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $28.67M, a 12.67% increase from fiscal 2021.
  • Inari Medical, Inc. share-based payment arrangement, noncash expense for fiscal 2021 was $25.45M, a 622.13% increase from fiscal 2020.
  • Inari Medical, Inc. share-based payment arrangement, noncash expense for fiscal 2020 was $3.52M, a 597.82% increase from fiscal 2019.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 month
2024-09-30$12.95M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-28
$25.99M
derived: sum of 2 quarters · filed 2024-10-28
$38.86M
10-Q · filed 2024-10-28
$48.66M
derived: sum of 4 quarters · filed 2024-10-28
2024-06-30$13.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30
$25.91M
10-Q · filed 2024-07-30
$35.71M
derived: sum of 3 quarters · filed 2024-07-30
$45.55M
derived: sum of 4 quarters · filed 2024-10-28
2024-03-31$12.87M
10-Q · filed 2024-04-30
$22.67M
derived: sum of 2 quarters · filed 2024-04-30
$32.52M
derived: sum of 3 quarters · filed 2024-10-28
$42.87M
derived: sum of 4 quarters · filed 2024-10-28
2023-12-31$9.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$19.64M
derived: sum of 2 quarters · filed 2024-10-28
$30.00M
derived: sum of 3 quarters · filed 2024-10-28
$40.34M
10-K · filed 2024-02-29
2023-09-30$9.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-28
$20.20M
derived: sum of 2 quarters · filed 2024-10-28
$30.54M
10-Q · filed 2024-10-28
$38.13M
derived: sum of 4 quarters · filed 2024-10-28
2023-06-30$10.35M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30
$20.69M
10-Q · filed 2024-07-30
$28.29M
derived: sum of 3 quarters · filed 2024-07-30
$35.64M
derived: sum of 4 quarters · filed 2024-07-30
2023-03-31$10.34M
10-Q · filed 2024-04-30
$17.93M
derived: sum of 2 quarters · filed 2024-04-30
$25.29M
derived: sum of 3 quarters · filed 2024-04-30
$32.45M
derived: sum of 4 quarters · filed 2024-04-30
2022-12-31$7.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$14.95M
derived: sum of 2 quarters · filed 2024-02-29
$22.12M
derived: sum of 3 quarters · filed 2024-02-29
$28.67M
10-K · filed 2024-02-29
2022-09-30$7.36M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01
$14.52M
derived: sum of 2 quarters · filed 2023-11-01
$21.07M
10-Q · filed 2023-11-01
$25.58M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$7.16M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02
$13.72M
10-Q · filed 2023-08-02
$18.23M
derived: sum of 3 quarters · filed 2024-02-29
$30.73M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31$6.55M
10-Q · filed 2023-05-03
$11.06M
derived: sum of 2 quarters · filed 2024-02-29
$23.56M
derived: sum of 3 quarters · filed 2024-02-29
$28.17M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$4.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$17.01M
derived: sum of 2 quarters · filed 2024-02-29
$21.61M
derived: sum of 3 quarters · filed 2024-02-29
$25.45M
10-K · filed 2024-02-29
2021-09-30$12.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02
$17.10M
derived: sum of 2 quarters · filed 2022-11-02
$20.94M
10-Q · filed 2022-11-02
$22.50M
derived: sum of 4 quarters · filed 2023-02-27
2021-06-30$4.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03
$8.44M
10-Q · filed 2022-08-03
$10.01M
derived: sum of 3 quarters · filed 2023-02-27
$10.96M
derived: sum of 4 quarters · filed 2023-02-27
2021-03-31$3.84M
10-Q · filed 2022-05-04
$5.40M
derived: sum of 2 quarters · filed 2023-02-27
$6.36M
derived: sum of 3 quarters · filed 2023-02-27
$6.87M
derived: sum of 4 quarters · filed 2023-02-27
2020-12-31$1.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27
$2.52M
derived: sum of 2 quarters · filed 2023-02-27
$3.03M
derived: sum of 3 quarters · filed 2023-02-27
$3.52M
10-K · filed 2023-02-27
2020-09-30$959.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$1.47M
derived: sum of 2 quarters · filed 2021-11-09
$1.96M
10-Q · filed 2021-11-09
$2.13M
derived: sum of 4 quarters · filed 2022-02-23
2020-06-30$506.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10
$1.00M
10-Q · filed 2021-08-10
$1.18M
derived: sum of 3 quarters · filed 2022-02-23
$1.31M
derived: sum of 4 quarters · filed 2022-02-23
2020-03-31$494.00K
10-Q · filed 2021-05-11
$670.00K
derived: sum of 2 quarters · filed 2022-02-23
$809.00K
derived: sum of 3 quarters · filed 2022-02-23
2019-12-31$176.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23
$315.00K
derived: sum of 2 quarters · filed 2022-02-23
$505.00K
10-K · filed 2022-02-23
2019-09-30$139.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
$329.00K
10-Q · filed 2020-11-12
2019-06-30$190.00K
10-Q · filed 2020-08-11
2018-12-31$248.00K
10-K · filed 2021-03-09